Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1978-06-07
1979-09-18
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Lymphokine
260112B, 424 86, 424 87, A61K 3706
Patent
active
041683030
ABSTRACT:
Freeze-drying of an aqueous solution of human native gamma globulin having an anticomplementary activity of 20 (C'H50) or less in the presence of 0.06 to 0.26 part by weight of a neutral inorganic salt for 1 part by weight of the gamma globulin gives an immunoactive lyophilized native gamma globulin preparation which has undergone neither increase in anticomplementary activity nor deterioration in antibody activity during the freeze-drying and is safe for use in intravenous administration.
REFERENCES:
patent: 2793203 (1957-05-01), Schultze et al.
patent: 3466368 (1969-09-01), Sela et al.
patent: 3903262 (1975-09-01), Pappenhagen et al.
patent: 3966906 (1976-06-01), Schultze et al.
patent: 4021540 (1977-05-01), Pollack et al.
patent: 4027010 (1977-05-01), Kiselev et al.
patent: 4087519 (1978-05-01), Trepo
Fujita Shigeru
Nishida Masayuki
Saki Toshiyuki
Yabushita Sadao
Daus Donald G.
Eakin M. C.
The Green Cross Corporation
LandOfFree
Lyophilized native gamma globulin preparation for intravenous ad does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lyophilized native gamma globulin preparation for intravenous ad, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lyophilized native gamma globulin preparation for intravenous ad will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-897739